Skip to main content
Clinical Trials/ACTRN12610000296033
ACTRN12610000296033
Recruiting
N/A

A study examining the physical, psychological and cognitive effects following commencement of continuous subcutaneous insulin infusion therapy (CSII) in Type I Diabetes.

Medtronic0 sites30 target enrollmentApril 13, 2010

Overview

Phase
N/A
Intervention
Not specified
Conditions
Type 1 diabetes
Sponsor
Medtronic
Enrollment
30
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 13, 2010
End Date
TBD
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Medtronic

Eligibility Criteria

Inclusion Criteria

  • Patients with Type 1 Diabetes commencing CSII therapy
  • Age 18 years to 69 years
  • The capacity to give and accept informed consent to participate in the research

Exclusion Criteria

  • Age under 18 years or \>\=70 years
  • Chronic renal disease, stage III or IV
  • Psychosis or psychiatric disorder
  • Active cancer within last 5 years
  • Inability to provide informed consent (i.e. has an intellectual disability, dementia)
  • Unable to communicate in English

Outcomes

Primary Outcomes

Not specified

Similar Trials